Market Cap (In INR)
172.09 Million
Revenue (In INR)
154.24 Million
Net Income (In INR)
-1.04 Million
Avg. Volume
671.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 15.2-52.05
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- INE240T01014
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- -
- Employee Count
- -
- Website
- -
- Ipo Date
- Details
- Parmax Pharma Ltd. engages in the manufacture of bulk drugs like ampicilin, amoxycillin, cephalexin, and nalidixic acid. The company also plans to extend its activities in formulation of tablets, capsules, ointments, & injectable. The company was founded on November 2, 1994 and is headquartered in Rajkot, India.
More Stocks
-
BRYFFBri-Chem Corp.
BRYFF
-
LGIHLGI Homes, Inc.
LGIH
-
HRL
-
0172OCK Group Berhad
0172
-
688558
-
BUAH
-
0764
-
5541